Accessibility Menu
 
Bio-Techne logo

Bio-Techne

(NASDAQ) TECH

Current Price$57.36
Market Cap$8.97B
Since IPO (1992)+10,614%
5 Year-44%
1 Year+15%
1 Month+12%

Bio-Techne Financials at a Glance

Market Cap

$8.97B

Revenue (TTM)

$1.22B

Net Income (TTM)

$81.10M

EPS (TTM)

$0.51

P/E Ratio

111.57

Dividend

$0.32

Beta (Volatility)

1.16 (Average)

Price

$57.36

Volume

1.073

Open

$58.11

Previous Close

$57.36

Daily Range

$56.80 - $58.47

52-Week Range

$46.01 - $72.16

TECH: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Techne

Industry

Life Sciences Tools and Services

Employees

3,100

CEO

Kim Kelderman

Headquarters

Minneapolis, MN 55413, US

TECH Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

10%

Net Income Margin

7%

Return on Equity

4%

Return on Capital

5%

Return on Assets

3%

Earnings Yield

0.90%

Dividend Yield

0.01%

Payout Ratio

61.50%

Stock Overview

Market Cap

$8.97B

Shares Outstanding

156.45M

Volume

1.073

Short Interest

0.00%

Avg. Volume

2.36M

Financials (TTM)

Gross Profit

$790.27M

Operating Income

$102.25M

EBITDA

$216.88M

Operating Cash Flow

$287.56M

Capital Expenditure

$31.01M

Free Cash Flow

$256.55M

Cash & ST Invst.

$162.19M

Total Debt

$444.06M

Bio-Techne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$295.88M

-0.4%

Gross Profit

$191.28M

-1.3%

Gross Margin

64.65%

N/A

Market Cap

$8.97B

N/A

Market Cap/Employee

$2.89M

N/A

Employees

3,100

N/A

Net Income

$38.01M

+8.9%

EBITDA

$77.66M

+7.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$178.02M

+18.2%

Accounts Receivable

$184.61M

-15.3%

Inventory

$205.45M

+9.1%

Long Term Debt

$337.19M

-11.6%

Short Term Debt

$13.71M

+1.5%

Return on Assets

3.21%

N/A

Return on Invested Capital

4.91%

N/A

Free Cash Flow

$76.49M

-1.3%

Operating Cash Flow

$82.41M

-2.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$40.96-1.63%
BMRNBioMarin Pharmaceutical Inc.
$54.10-2.12%
EXELExelixis, Inc.
$44.38+0.23%
MDGLMadrigal Pharmaceuticals, Inc.
$524.76+1.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
PBMPsyence Biomedical
$5.87+1.04%
NVDANvidia
$198.43-0.00%
INTCIntel
$68.52+0.06%
TSLATesla
$389.23-0.01%

Questions About TECH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.